There has been increasing research momentum to identify new therapeutic agents for the
prevention or treatment of preeclampsia, drugs that can affect the underlying disease …

This systematic review was conducted to gather evidence of preeclampsia occurring before
the 20th week of gestation, additionally considering the role of PLGF and sFlt-1 in the …

Since the 1970s, we have known that aspirin can reduce the risk of pre‐eclampsia.
However, the underlying mechanisms explaining this risk reduction are poorly understood …

Background There have been safety concerns considering long‐term proton pump inhibitor
(PPI) use, also during pregnancy. Aims To assess the risk of adverse neonatal outcomes …

Preeclampsia, a serious complication of pregnancy, involves intricate molecular and cellular
mechanisms. Fetal microchimerism, where fetal cells persist within maternal tissues and in …

Background Approximately half of all women suffer from heartburn at some stage during
pregnancy. The most effective treatment is proton pump inhibitors, but the safety of use …

We provide an updated framework of the current approaches to define and diagnose
preeclampsia. Disease modifying therapies (in particular, targeting the angiogenic pathway) …

Chronic kidney disease (CKD) can have an insidious onset because there is a gradual
decline in nephron number throughout life. There may be no overt symptoms of renal …

Gastroesophageal reflux disease (GERD) is one the most common medical complaints in
pregnant women. Some women continue to experience GERD symptoms after delivery …

The cholinergic anti-inflammatory pathway (CAP) is vital for the orchestration of the immune
and inflammatory responses under normal and challenged conditions. Over the past two …